Trials / Unknown
UnknownNCT04669184
Sarcopenia and Physical Performance in Hemodialysis Patients
Assessment of Sarcopenia, Physical Performance and Cognitive Function in Hemodialysis Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (estimated)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of this study was to investigate the relationship between physical performance and sarcopenia, peripheral muscle strength, activities of daily living, cognitive functions, physical activity level, fragility, pain in hemodialysis patients.
Detailed description
A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabolic processes in chronic kidney disease. Sarcopenia and physical inactivity progress synergistically. Decreased physical performance is associated with sarcopenia. In hemodialysis patients, daily physical activity level and physical performance decrease. Cognitive impairment is common in chronic kidney disease. Uremic toxins can cause a decrease in cognitive function. One of the most important problems associated with hemodialysis is pain and pain negatively affects functional capacity and quality of life.
Conditions
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-12-01
- Completion
- 2022-03-01
- First posted
- 2020-12-16
- Last updated
- 2020-12-16
Source: ClinicalTrials.gov record NCT04669184. Inclusion in this directory is not an endorsement.